A Systematic Review and a Meta-Analysis Comparing Prophylactic and Therapeutic Low Molecular Weight Heparins for Mortality Reduction in 32,688 COVID-19 Patients

A Systematic Review and a Meta-Analysis Comparing Prophylactic and Therapeutic Low Molecular Weight Heparins for Mortality Reduction in 32,688 COVID-19 Patients

Background: Antithrombotic treatment, including low molecular weight heparin (LMWH) or unfractionated heparin (UFH), has been proposed as a potential therapy for coronavirus disease 2019 (COVID-19) to lower diffuse intravascular clotting activation. However, it is unclear whether prophylactic or the...

Full description

Bibliographic Details
Main Authors: Riccardo Giossi, Danilo Menichelli, Arianna Pani, Elena Tratta, Alessandra Romandini, Rossana Roncato, Alessandro Nani, Paolo Schenardi, Erika Diani, Veronica Andrea Fittipaldo, Alessio Farcomeni, Francesco Scaglione, Daniele Pastori
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-09-01
Series:Frontiers in Pharmacology
Subjects:
SARS-CoV2
COVID-19
mortality
heparin
LMWH
bleeding
Online Access:https://www.frontiersin.org/articles/10.3389/fphar.2021.698008/full

Internet

https://www.frontiersin.org/articles/10.3389/fphar.2021.698008/full

Similar Items